Related research shows blood or urine sample can be used
UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the Annual Meeting of American Association for the Study of Liver Disease (AASLD) in San Francisco, Nov. 14-16. Current blood-based HCV testing requires two steps and can be expensive, inconvenient and is not widely available or affordable globally.
“Our novel HCV antigen test system has significantly improved sensitivity and specificity over current tests. Importantly, for the first time, we can use urine specimens for one-step screening and diagnosing of HCV infection,” said Hu, professor of gastroenterology and hepatology at UC Irvine School of Medicine. “Finding a more convenient, easy-to-use and cost-effective screening alternative is imperative, because HCV is significantly under-screened and under-diagnosed.”
Although the current HCV screening test is specific and sensitive, it cannot distinguish active infection from a previous infection. A blood sample is required, and two steps are required. First, virus-specific antibodies must be detected in the blood. Then, the sensitive HCV RNA PCR test must be administered to confirm whether or not the infection is active. Hu said many developing countries are not equipped to administer the two-step test, especially the HCV RNA PCR test. In the U.S., its cost is above $200. The novel HCV antigen test system developed by Hu’s UC Irvine lab could significantly reduce the cost, human resources and time required for the test results.
“The ability to detect infection using urine rather than blood avoids needle stick and blood sample collection, greatly reduces the cost and necessary clinical infrastructure for screening and diagnosis, helping to promote widespread adoption of the test on a global scale,” Hu said.
According to the Centers for Disease Control and Prevention, approximately 150 million people worldwide and 3.2 million people in the U.S. are infected with HCV. Effective screening and fast diagnosis are critical for treatment and controlling transmission.
“Those who are HCV infected can now be cured, before a further liver injury and complications develop, but only if they are diagnosed” Hu said.
The Latest on: Hepatitis C
via Google News
The Latest on: Hepatitis C
- We went to a class on hepatitis A. Here’s what we learned.on August 16, 2019 at 8:32 am
Johnsen began his class by explaining the differences between hepatitis A, B and C. All three infections affect the liver; there are only vaccines for hepatitis A and B. Both hepatitis B and C are ...
- Minnesota's hepatitis A outbreak highlights risk for workerson August 16, 2019 at 7:55 am
A transient illness, Hepatitis A is distinct from Hepatitis C, which is chronic. But the illness can nonetheless live on surfaces, has no drug treatment and can cause severe liver damage in some cases ...
- Hepatitis C and three cancers now covered on basic plan in Dubaion August 16, 2019 at 2:45 am
Patients must be a resident visa holder to benefit from the Basmah initiative. Image Credit: Antonin Kélian Kallouche/Gulf News Archives Dubai: Dubai residents are now covered for screening and ...
- War on hepatitis can only be won through public awarenesson August 15, 2019 at 11:18 pm
In Kenya, rising cases of chronic hepatitis B (HBV) in the general population and high infection rates of hepatitis C (HCV) among people who inject drugs (PWIDs) continue to pose great challenges to ...
- Hepatitis A races across the countryon August 15, 2019 at 8:09 pm
How is hepatitis A different from other types of hepatitis? Hepatitis A, B and C are caused by different viruses. Hepatitis B is primarily spread when blood, semen or certain other body fluids from an ...
- Prisons will add staff to screen for Hepatitis Con August 15, 2019 at 1:55 pm
The Department of Correction could temporarily hire about 30 staff members to start testing its inmates for Hepatitis C sometime over the next month, a spokesperson said Thursday afternoon.
- Facing class action lawsuit, prison system announces plan to test and treat all inmates for hepatitis C at a cost that could exceed $150Mon August 13, 2019 at 2:42 pm
Facing a class action lawsuit, the Department of Correction has said it will begin testing and treating inmates for the hepatitis C virus, which can be spread by unprotected sex, intravenous drug use ...
- Correction Department to begin testing, treating inmates for Hepatitis Con August 13, 2019 at 12:20 pm
The Department of Correction says it will begin testing and treating inmates for the Hepatitis C virus this fall. The department’s announcement was issued in an Aug. 7 memorandum from ...
- 'Curing' Hepatitis C Is Not the End of Patient Careon August 12, 2019 at 10:49 am
Norah Terrault, MD, MPH, will never forget the patient who slipped away. He was in late middle age and had lived with hepatitis C for several decades before undergoing treatment. Antiviral drugs ...
- Study proves hepatitis C drugs reduce liver-related deaths by nearly halfon August 9, 2019 at 1:31 pm
A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of ...
via Bing News